Text Size
410 studies found for:    Open Studies | "Arthritis, Rheumatoid"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Arthritis, Rheumatoid"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The Predictive Value of Ultrasound in Early Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis;   Predictive Value of Ultrasound in Early Rheumatoid Arthritis
Intervention:
2 Recruiting An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis
Conditions: Arthritis;   Arthritis, Rheumatoid;   Joint Diseases;   Musculoskeletal Diseases;   Rheumatic Diseases;   Connective Tissue Diseases;   Autoimmune Diseases
Interventions: Procedure: Magnetic resonance imaging (MRI);   Other: Conventional biochemical and clinical examinations
3 Not yet recruiting Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid;   Neovascularization, Pathologic;   Synovitis
Intervention:
4 Recruiting Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Drug: Milnacipran
5 Unknown † Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid;   Vitamin D Deficiency
Interventions: Drug: Placebo in arm A and Vitamin D in arm B;   Drug: vitamin D 3 for arm A ,and matching placebo for arm B
6 Recruiting A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: Sirukumab;   Drug: Midazolam;   Drug: Warfarin;   Drug: Vitamin K;   Drug: Omeprazole;   Drug: Caffeine
7 Recruiting A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Biological: adalimumab;   Drug: Methotrexate
8 Recruiting A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: ASP015K;   Drug: Placebo
9 Recruiting A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects
Condition: Arthritis, Rheumatoid
Interventions: Drug: ASP015K;   Drug: Placebo
10 Recruiting A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate
Condition: Arthritis, Rheumatoid
Interventions: Drug: ASP015K;   Drug: Placebo
11 Recruiting A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy
Condition: Arthritis, Rheumatoid
Interventions: Drug: Placebo + methotrexate (MTX) (Group 1);   Drug: Ustekinumab + MTX (Group 2);   Drug: Ustekinumab + MTX (Group 3);   Drug: CNTO 1959 + MTX (Group 4);   Drug: CNTO 1959 + MTX (Group 5)
12 Recruiting A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine
Condition: Arthritis, Rheumatoid
Interventions: Drug: Sirukumab 100 mg;   Drug: Sirukumab 50 mg;   Drug: Placebo
13 Recruiting A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND)
Condition: Arthritis, Rheumatoid
Interventions: Drug: Placebo;   Drug: Sirukumab
14 Recruiting A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND)
Condition: Arthritis, Rheumatoid
Interventions: Drug: Placebo;   Drug: Sirukumab
15 Recruiting Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Drug: CP-690,550
16 Recruiting Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: PRTX-100 at 1.5 mcg/kg;   Drug: PRTX-100 at 3.0 mcg/kg;   Drug: PRTX-100 at 6.0 mcg/kg;   Drug: PRTX-100 at 12.0 mcg/kg;   Drug: PRTX-100 at 18.0 mcg/kg;   Drug: Placebo
17 Recruiting Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: BI 695500;   Drug: rituximab
18 Unknown † Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes
Conditions: Fatigue Syndrome, Chronic;   Fibromyalgia;   Arthritis, Rheumatoid
Interventions: Drug: citalopram;   Drug: 1 ml 0.9 % NaCl
19 Recruiting A Study to Validate Questionnaires FLARE and OM-RA-FLARE Measuring Disease Flares in Patients With Rheumatoid Arthritis.
Condition: Arthritis, Rheumatoid
Intervention: Other: Questionnaire
20 Unknown † Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker
Conditions: Arthritis, Rheumatoid;   Spondylitis, Ankylosing
Intervention: Drug: TNF blockers (infliximab, adalimumab, etanercept)
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years